Although it may be difficult to obtain ascites from healthy people for early diagnosis of ovarian cancer, these findings raise the possibility that ascitic ATX levels may help to distinguish relatively inactive and aggressive tumours and that they may be useful in identifying ovarian cancers with different drug responses even at the same stage, thereby aiding clinicians in making decisions and providing optimal treatment and monitoring. Here, ENPP2 is linked to ovarian cancer.